Valuing Child and Adolescent Health States to Derive Utilities for Use in Economic Evaluation: A Good Practices Report of an ISPOR Task Force
Value in Health · 2026-04 · 29 (4) · 535-546
DOI: 10.1016/j.jval.2025.12.016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Value in Health, 2026-04. Verfasst von Louis S Matza und 11 weiteren Autor:innen. Beteiligte Einrichtung: PPD Evidera Patient-Centered Research, Thermo Fisher Scientific, Waltham, MA, USA. Hauptthemen laut MEDLINE: Adolescent Health, Child Health, Health Status, Technology Assessment, Biomedical. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 98 Literaturangaben.
Abstract (Originalsprache)
Economic evaluations of interventions that target or include children require health state utilities (HSUs). Despite the availability of preference-weighted measures for children, methods for valuing child health states and estimating child utilities are not as well established as those for adult HSUs. The objective of this task force was to develop emerging good practice recommendations for valuing child and adolescent health to generate HSUs for use in economic evaluation. This task force identified and described the interrelated methodological choices regarding the valuation of child health to generate HSUs. The task force considered available evidence related to 4 key issues: (1) whose preferences should be sought, (2) whose health is imagined, (3) which method should be used, and (4) the comparability between adult and child utilities. Best practices may vary depending on the modeling context, characteristics of the health states, and the health technology assessment setting in which the HSUs will be used. For any individual study, methods will be informed by empirical evidence, value judgments, and recommendations from healthcare decision makers. Rather than recommending an approach that would apply to every study, this task force presents options to consider when determining the preference elicitation approach to generate utilities for child health states, along with the strengths and limitations of each. Given that child HSUs can affect the outcomes of a cost-utility analysis and subsequent decisions about healthcare resource allocation, this task force recommends that researchers be transparent about methodological choices and their impact on HSUs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- PPD Evidera Patient-Centered Research, Thermo Fisher Scientific, Waltham, MA, USA.
- Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, South Yorkshire, England, UK. Electronic address: d.rowen@sheffield.ac.uk.
- Duchenne UK, London, England, UK.
- Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
- French National Authority for Health (Haute Autorité de Santé), Saint Denis, France.
- HTA, Value & Evidence Strategy, Pfizer Inc, New York, NY, USA.
Zitieren
APA
Matza, L. S., Rowen, D., Chandler, F., Dalziel, K., Ghabri, S., Law, E. H., Prosser, L. A., Rivero-Arias, O., Shah, K., Stolk, E., Wolff, J., & Devlin, N. (2026). Valuing Child and Adolescent Health States to Derive Utilities for Use in Economic Evaluation: A Good Practices Report of an ISPOR Task Force. Value in Health, 29(4), 535-546. https://doi.org/10.1016/j.jval.2025.12.016
Vancouver
Matza LS, Rowen D, Chandler F, Dalziel K, Ghabri S, Law EH, et al. Valuing Child and Adolescent Health States to Derive Utilities for Use in Economic Evaluation: A Good Practices Report of an ISPOR Task Force. Value in Health. 2026;29(4):535-546. doi:10.1016/j.jval.2025.12.016
BibTeX
@article{Matza2026,
author = {Matza, Louis S and Rowen, Donna and Chandler, Fleur and Dalziel, Kim and Ghabri, Salah and Law, Ernest H and Prosser, Lisa A and Rivero-Arias, Oliver and Shah, Koonal and Stolk, Elly and Wolff, Jonathan and Devlin, Nancy},
title = {Valuing Child and Adolescent Health States to Derive Utilities for Use in Economic Evaluation: A Good Practices Report of an ISPOR Task Force},
journal = {Value in Health},
year = {2026},
volume = {29},
number = {4},
pages = {535--546},
doi = {10.1016/j.jval.2025.12.016}
}
EUVIMED